MCRPC
Clinical trials for MCRPC explained in plain language.
Never miss a new study
Get alerted when new MCRPC trials appear
Sign up with your email to follow new studies for MCRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial tests new hope for men with Tough-to-Treat prostate cancer
Disease control OngoingThis large, late-stage study is testing whether adding a new drug called talazoparib to a standard prostate cancer treatment (enzalutamide) works better for controlling advanced disease. It involved over 1,000 men whose cancer had spread and stopped responding to standard hormone…
Matched conditions: MCRPC
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early trial launches for aggressive prostate cancer combo
Disease control OngoingThis early-stage trial is testing the safety and initial effectiveness of combining two antibody drugs for men with metastatic castration-resistant prostate cancer (mCRPC). The study involves a very small group of 7 participants to see if the drug combination is safe and if it ca…
Matched conditions: MCRPC
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC